Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2025-07-02 00:00:00 ET · period of report 2025-06-30 · accession 0001610717-25-000274 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-02 | 2025-06-30 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.54 | +37.0K | 465.7K | +9% | +$20.0K |
| D | 2025-07-02 | 2025-06-30 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.00 | -37.0K | 168.5K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-30 | M | A | 37,000 | $0.54 | 465,720 | D | — | — | (F1) Includes 218,188 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-06-30 | M | D | 37,000 | $0.00 | 168,503 | D | $0.54 · 2022-03-01 to 2028-02-11 | 37,000 Common Stock |